An Unexpected Result of Obesity Treatment: Orlistat-Related Acute Pancreatitis
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Orlistat is a pancreatic lipase inhibitor which is used to treat obesity. Due to the increasing prevalence of obesity, orlistat use is thought to rise progressively. We report an interesting case caused by orlistat use caught in the early stages of acute pancreatitis through imaging; in addition, the case had significantly elevated serum amylase levels. A 54-year-old male who had a history of orlistat treatment started 7 days before was admitted to the emergency department with complaints of abdominal pain, nausea and vomiting lasting for 24 h. Abdominal computed tomography revealed peripancreatic fat tissue edema and a heterogeneous appearance of the pancreas. Based on these findings, it was concluded that edematous pancreatitis was in its initial stage. Orlistat is a drug that is increasingly widespread use due to obesity. More attention must be paid when planning to prescribe orlistat to patients if there are risk factors for acute pancreatitis (alcohol use, height, serum calcium and lipid levels).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Side effects include oily discharge with flatus from the rectum, fecal urgency, and increased defecation and fecal incontinence, especially after fatty food intake.”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“May promote gallstones and kidney stones.”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Contraindicated in chronic malabsorption syndrome and cholestasis.”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“May cause malabsorption of fat-soluble vitamins (A, D, E, K).”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Approved for patients 12 years or older.”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [48]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whitcomb, D. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp054958 · Cited by 745
Orlistat-Associated Adverse Effects and Drug Interactions: A Critical Review
Filippatos, T. D., Derdemezis, C. S., Gazi, I. F., Nakou, E. S., Mikhailidis, D. P., & Elisaf, M. S. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00005 · Cited by 434
Guerciolini, R. (1997) · PubMed · Cited by 331
Drug-Induced Pancreatitis: Incidence, Management and Prevention
Balani, A. R., & Grendell, J. H. (2008) · Drug Safety · doi:10.2165/00002018-200831100-00002 · Cited by 285
Drug-induced acute pancreatitis: a review.
Jones, M. R., Hall, O. M., Kaye, A. M., & Kaye, A. D. (2015) · PubMed · Cited by 251
Wilmink, T. B. M., & Frick, T. W. (1996) · Drug Safety · doi:10.2165/00002018-199614060-00006 · Cited by 140
Orlistat (Xenical)-induced subacute liver failure
Thurairajah, P. H., Syn, W., Neil, D., Stell, D. A., & Haydon, G. H. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000187680.53389.88 · Cited by 54
Orlistat associated subacute hepatic failure
Montero, J. L., Muntané, J., Fraga, E., Delgado, M. B., Costán, G., Serrano, M., Ruiz, F. J. P., de la Mata, M., & Miño, G. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00042-8 · Cited by 37
Acute Pancreatitis Following Orlistat Therapy: Report of Two Cases
Ahmad, F., & Mahmud, S. (2016) · PubMed · doi:10.6092/1590-8577/3874 · Cited by 35
Napier, S., & Thomas, M. G. (2006) · Nutrition Journal · doi:10.1186/1475-2891-5-19 · Cited by 33
Cited by
Khatua, B., El-Kurdi, B., & Singh, V. P. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000386 · Cited by 206
Mechanisms underlying UCP1 dependent and independent adipocyte thermogenesis
Chang, S., Song, N., Choi, J. H., Yun, U. J., & Park, K. W. (2018) · Obesity Reviews · doi:10.1111/obr.12796 · Cited by 115
Induction of thermogenic adipocytes: molecular targets and thermogenic small molecules
Song, N.-J., Chang, S., Li, D. Y., Villanueva, C. J., & Park, K. W. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.70 · Cited by 84
Bays, H. E., Fitch, A., Christensen, S., Burridge, K., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100018 · Cited by 68
“[18,44,48,60,85] Gastrointestinal events may increase when orlistat is taken with a diet high in fat ( > 30% total daily calories from fat).”
BackgroundDiscovery of Arginine-Containing Tripeptides as a New Class of Pancreatic Lipase Inhibitors
Stefanucci, A., Luisi, G., Zengin, G., Macedonio, G., Dimmito, M. P., Novellino, E., & Mollica, A. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0216 · Cited by 60
Rehman, K., Munawar, S. M., Akash, M. S. H., Buabeid, M. A., Chohan, T. A., Tariq, M., Jabeen, K., & Arafa, E. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227637 · Cited by 51
Zhu, J., Hu, M., Liang, Y., Zhong, M., Chen, Z., Wang, Z., Yang, Y., Luo, Z., Zeng, W., Li, J., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34837 · Cited by 42
Borel, P., Dangles, O., & Kopec, R. E. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101220 · Cited by 36
Clinical Practice Recommendations for the Management of Obesity in the United Arab Emirates
Abusnana, S., Fargaly, M., Alfardan, S. H., Hammadi, F. H. A., Bashier, A. M., KADDAHA, G., McGowan, B. M., Nawar, R., & Sadiya, A. (2018) · Obesity Facts · doi:10.1159/000491796 · Cited by 31
Souto, M., Gonçalves, T. C., & Cotter, J. B. (2025) · Nutrients · doi:10.3390/nu17142310 · Cited by 26
“The underlying mechanism remains uncertain but may involve direct toxicity or hypersensitivity [109].”
Lee, D. H., Chang, S., Yang, D. K., Song, N., Yun, U. J., & Park, K. W. (2020) · Nutrients · doi:10.3390/nu12051459 · Cited by 24
Candela, C. G., Milla, S. P., Miján-de-la-Torre, A., Ortega, P. R., Martín, P. M., Cohen, V. L., Portillo, R. C. D., Casas, M. ª. N. V., Olmos, M. Á. M., Álvarez, M. ª. T. M., et al. (2017) · Nutrición Hospitalaria · doi:10.20960/nh.1562 · Cited by 34
Palvannan, T., Nallaiyan, S., Loganathan, C., Sakayanathan, P., Kandasamy, S., & Isa, M. A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.215 · Cited by 20
Alsuhibani, A., Alrasheed, M., Gari, M., Hincapie, A. L., & Guo, J. J. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01330-2 · Cited by 19
Reyad‐ul‐Ferdous, M., & Song, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.285 · Cited by 18
Youssef, S. S. (2018) · Forensic Medicine and Anatomy Research · doi:10.4236/fmar.2018.62003 · Cited by 18
“Pancreatitis associated with the use of orlistat was also recorded by several investigators [14] [15].”
Susceptible genetic polymorphisms and their association with adverse effects of orlistat therapy
Logesh, R., Radhakrishnan, A., Selleppan, G., & Mohankumar, S. K. (2021) · Obesity Medicine · doi:10.1016/j.obmed.2021.100360 · Cited by 10
“The adverse consequences of orlistat therapy include gastrointestinal dysfunction, pancreatitis, sub-acute hepatic injury, acute oxalate nephropathy, and renal failure (Davidson et al., 1999; Finer et al., 2000; Kose et al., 2015; Qi, 2018).”
BackgroundReyad‐ul‐Ferdous, M., Song, Y., Zhang, H., & Pandey, V. (2022) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2022.101571 · Cited by 7
“Impeding the absorption of food fat in the digestive system is an alternative methodology [5–10].”
Rehman, K., Munawar, S. M., Akash, M. S. H., Buabeid, M. A., Chohan, T. A., Tariq, M., Jabeen, K., & Arafa, E. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229348 · Cited by 7
Obesity Medications and Their Impact on Cardiovascular Health: A Narrative Review
Islam, K. N., Islam, R. K., Tong, V. T., Shami, M. Z., Allen, K. E., Brodtmann, J. R., & Book, J. A. (2024) · Cureus · doi:10.7759/cureus.71875 · Cited by 6
Reyad‐ul‐Ferdous, M., Abdalla, M., Yang, M., Xiaoling, L., Bian, W., Xie, J., & Song, Y. (2022) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2022.101516 · Cited by 6
“Impeding the absorption of food fat in the digestive system is an alternative methodology [5].”
Effect of Orlistat on the pancreas of the female albino rat: Histological and Histochemical study
Abdelwahab, S. A., Ali, A., & Mahmoud, A. (2017) · Journal of Medical Histology/Journal of Medical Histology · doi:10.21608/jmh.2017.846.1009 · Cited by 6
Camacho-Ruiz, M. D. L. A., Ordaz, E., Kirchmayr, M. R., Esquivel‐Solís, H., Asaff‐Torres, A., Mateos‐Díaz, J. C., Carrière, F., & Rodríguez, J. A. (2019) · International Microbiology · doi:10.1007/s10123-019-00107-y · Cited by 3
Balli, M. L. (2026) · Journal of Pharmacy Practice · doi:10.1177/08971900261416787 · Cited by 2
“15 Acute pancreatitis has been reported in post marketing reports for bupropion and naltrexone, components of the extended-release CONTRAVE product.”
An Overview of Modern Strategies for Treating Obesity
Jędrasek, A., Barg, M., Biały-Karbowniczek, J., Bartela, A., & Wojtyła, K. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.68.49506 · Cited by 2
Chang, S., Song, D., Oh, S., Han, S.-A., Jung, J.-M., Song, N., Kang, H. G., Lee, S., Ahn, J., Ahn, S., et al. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106820 · Cited by 2
Reyad‐ul‐Ferdous, M., Yang, M., Azam, M. S., Song, Y., Zhang, H., & panday, V. (2024) · Physiology and Pharmacology · doi:10.61186/phypha.28.4.465 · Cited by 1
Reyad‐ul‐Ferdous, M., Wolde, T., Pandey, V., & Qin, P. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2460738 · Cited by 1
“Another strategy is to prevent the digestive tract from absorbing dietary fat (Kose et al., 2015; Ul Ferdous, 2014).”
Koç, D. Ö., Sarbay, İ., Başpınar, M. M., Mangal, L., Arda, B. E., & Sipahi, H. (2026) · Pharmaceuticals · doi:10.3390/ph19091325 · Cited by 1
“Pancreatitis is described in the FDA prescribing information as a post-marketing event, and published case reports have documented acute pancreatitis following orlistat exposure [11,43–45].”
Orlistat for obesity management with high levels of TNFα in children
Bramasta, A. A., Hadianto, S. D. A., Eriady, T. C., Natalie, M. R., & Purwanto, N. P. (2023) · Science Midwifery · doi:10.35335/midwifery.v11i1.1192 · Cited by 1
Welston, K., & May, D. W. (2016) · Side effects of drugs annual · doi:10.1016/bs.seda.2016.08.012
Orlistat: Acute oedematous pancreatitis: case report
(2015) · Reactions Weekly · doi:10.1007/s40278-015-1397-9
Phentermine-induced pancreatitis: an unpopular side effect of the popular weight loss medication
Katamreddy, Y., Mandyam, S., Shankar, A., Fadeyi, O. A., Ilyas, Z., & Chou, B. (2024) · Discover Medicine · doi:10.1007/s44337-024-00130-7
“Liraglutide, semaglutide, orlistat, and topiramate are reportedly causing pancreatitis [7–9].”
Exploring Acute Pancreatitis After Orlistat Use: A Case Report
Qasim, A., Jyala, A., Thartori, O., Ghazanfar, H., Moore, S., & Shehi, E. (2025) · Cureus · doi:10.7759/cureus.80832
“Drug induced pancreatitis is considered a diagnosis of exclusion, and it requires the exclusion of the most common causes of pancreatitis, such as gallstones and alcohol [11].”
Orlistat-Induced Systemic Adverse Events: A Review of Case Reports And Public Health Implications
Kösedağ, M. (2026) · Recent trends in pharmacology. · doi:10.62425/rtpharma.1770239
Zarei, A., Hosseini, N., Ramezani, M., Alimoradian, A., & Changizi‐Ashtiyani, S. (2025) · Journal of Medicinal Plants · doi:10.66224/jmp.24.96.53
Das, N. R., & Sharma, T. (2026) · AIP conference proceedings · doi:10.1063/5.0318045
Metadata
- Authors
- Kose, M., Emet, S., Akpınar, T. S., Ilhan, M., Gok, A. F. K., Dadashov, M., & Tukek, T.
- Affiliations
- Istanbul University (TR)
- Corresponding author
- Emet, Samim
- Venue
- Case Reports in Gastroenterology
- Publisher
- S. Karger AG
- Published
- 2015-05-08
- Volume
- 9
- Issue
- 2
- Pages
- 152-155
- ISSN
- 1662-0631 (ISSN-L)
- PMC
- PMC4464098
- OpenAlex
- W1602325038
- Cited by
- 36
- References
- 16
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 1
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
- Locations
- Case Reports in Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
- Keywords
- orlistat, acute pancreatitis, drug-induced pancreatitis, obesity treatment, pancreatic lipase inhibitors, edematous pancreatitis, serum amylase, abdominal CT, adverse drug reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
